Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate SAGE-217 in Participants With Essential Tremor

ClinicalTrials.gov ID: NCT02978781

Public ClinicalTrials.gov record NCT02978781. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 1:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of SAGE-217 in the Treatment of Subjects With Essential Tremor

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is a three-part, multicenter, Phase 2a study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of SAGE-217 in adult participants with essential tremor.

Study identification

NCT ID
NCT02978781
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Biogen
Industry
Enrollment
34 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 23, 2017
Primary completion
Nov 21, 2017
Completion
Dec 4, 2017
Last update posted
Nov 27, 2023

2017

United States locations

U.S. sites
26
U.S. states
12
U.S. cities
26
Facility City State ZIP Site status
Sage Investigational Site Anniston Alabama 36207
Sage Investigational Site Little Rock Arkansas 72211
Sage Investigational Site Rogers Arkansas 72758
Sage Investigational Site Cerritos California 90703
Sage Investigational Site Fountain Valley California 92708
Sage Investigational Site Oceanside California 92056
Sage Investigational Site San Diego California 92103
Sage Investigational Site Englewood Colorado 80113
Sage Investigational Site Clearwater Florida 33756
Sage Investigational Site DeLand Florida 32720
Sage Investigational Site Lauderdale Lakes Florida 33319
Sage Investigational Site Orlando Florida 32806
Sage Investigational Site Ormond Beach Florida 32174
Sage Investigational Site St. Petersburg Florida 33713
Sage Investigational Site Tampa Florida 33612
Sage Investigational Site Atlanta Georgia 30331
Sage Investigational Site Decatur Georgia 30030
Sage Investigational Site Chicago Illinois 60612
Sage Investigational Site Urbana Illinois 61801
Sage Investigational Site Springfield Missouri 65802
Sage Investigational Site St Louis Missouri 63141
Sage Investigational Site Raleigh North Carolina 27612
Sage Investigational Site Cincinnati Ohio 45212
Sage Investigational Site Dayton Ohio 45417
Sage Investigational Site Nashville Tennessee 37232
Sage Investigational Site Fort Worth Texas 76104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02978781, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 27, 2023 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02978781 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →